Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro

Ovarian cancer is the second most common gynaecological malignancy and was diagnosed in over 7,000 women in 2011 in the UK. There are currently no reliable biomarkers available for use in a regular screening assay for ovarian cancer and due to characteristic late presentation (78% in stages III and...

Descripción completa

Detalles Bibliográficos
Autores principales: ROGERS-BROADWAY, KARLY-RAI, CHUDASAMA, DIMPLE, PADOS, GEORGE, TSOLAKIDIS, DIMITRIS, GOUMENOU, ANASTASIA, HALL, MARCIA, KARTERIS, EMMANOUIL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902066/
https://www.ncbi.nlm.nih.gov/pubmed/27211906
http://dx.doi.org/10.3892/ijo.2016.3531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902066/
https://www.ncbi.nlm.nih.gov/pubmed/27211906
http://dx.doi.org/10.3892/ijo.2016.3531

Ejemplares similares